Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 13, Issue 18, Pages 5279-5284Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5ob00211g
Keywords
-
Categories
Funding
- Cancer Research UK
- Pfizer Global Research and Development
- Cancer Research UK [15751] Funding Source: researchfish
Ask authors/readers for more resources
Regioselective sulfamoylation of primary hydroxyl groups enabled a 5-step synthesis (overall yield 17%) of the first reported small molecule inhibitor of sulfatase-1 and 2, ((2S, 3R, 4R, 5S, 6R)-4,5-dihydroxy-2-methoxy-6-((sulfamoyloxy)methyl) tetrahydro-2H-pyran-3-yl) sulfamic acid, which obviated the use of hydroxyl protecting groups and is a marked improvement on the reported 9-step synthesis (overall yield 9%) employing hazardous trifluoromethylsulfonyl azide. The sulfamoylation methodology was used to prepare a range of derivatives of 1, and inhibition data was generated for Sulf-2, ARSA and ARSB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available